Publications

  1. Curtis R, Roberts JC, Crook N, Decker-Palmer M, Khainar R, Baker JR, Ullman M, Koerper MA, Wu J, Nichol MB. Trends in prescribing practices for management of haemophilia:1999–2021. Haemophilia.2023;1-9. https://doi.org/10.1111/hae.14769

  2. Roberts JC, Kulkarni R, Kouides PA, Sidonio RF Jr, Carpenter SL, Konkle BA, Wu J, Ullman MM, Curtis R, Baker JR, Crook N, Nichol MB. Depression and anxiety in persons with Von Willebrand disease. Haemophilia. 2022 Dec 14. doi: 10.1111/hae.14725. Epub ahead of print. PMID: 36516311.

  3. Curtis R, Manco-Johnson M, Konkle BA, Kulkarni R, Wu J, Baker JR, Ullman M, Tran DQ Jr, Nichol MB. Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia-Hematology Utilization Group Study Part VII (HUGS VII). J Blood Med. 2022 May 9;13:229-241. doi: 10.2147/JBM.S354526. PMID: 35585877; PMCID: PMC9109905.

  4. Chen CX, Baker JR, Nichol MB. Economic burden of illness among persons with hemophilia B from HUGS Vb: examining the association of severity and treatment regimens with costs and annual bleed rates. Value in Health 2017; 20(8):1074-1082.

  5. Curtis R, Baker J, Riske B, Ullman M, Niu X, Norton Kristi, Lou M, Nichol MB. Young adults with hemophilia in the U.S.: demographics, comorbidities, and health status. American Journal of Hematology 2015; 90:S11-S16.

  6. Zhou Z, Koerper MA, Johnson KA, Riske B, Baker JR, Ullman M, Curtis RG, Poon J, Lou M, Nichol MB. Burden of illness: direct and indirect cost among persons with hemophilia A in the United States. Journal of Medical Economics 2015; 18(6):457-65.

  7. Niu X, Poon JL, Riske B, Zhou ZY, Ullman M, Lou M, Baker J, Koerper M, Curtis R, Nichol MB. Physical activity and health outcomes in persons with hemophilia B. Haemophilia 2014: 1-8.

  8. Poon J, Doctor JN, Nichol MB. Longitudinal changes in health-related quality of life for chronic disease: an example in hemophilia A. Journal of General Internal Medicine 2014; 29 Suppl 3:760-766.

  9. Poon J, Zhou Z, Doctor JN, Wu J, Ullman MM, Ross C, Riske B, Parish KL, Lou M, Koerper MA, Gwardy-Sridhar F, Forsberg AD, Curtis RG, Johnson KA. Quality of life in hemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia 2012; 18(5):699-707.

  10. Zhou Z, Riske B, Forsberg AD, Ullman M, Baker JR, Koerper MA, Curtis RG, Lou M, Wu J, Johnson KA. Self-reported barriers to hemophilia care in persons with factor VIII deficiency. American Journal of Preventive Medicine 2011; 41(6 Suppl 4):S346-53.

  11. Zhou Z, Wu J, Baker J, Curtis R, Forsberg A, Huszti H, Koerper M, Lou M, Miller R, Parish K, Riske B, Shapiro A, Ullman M, Johnson K. Hemophilia Utilization Group Study – Part Va (HUGS Va): design, methods and baseline data. Haemophilia 2011; 17(5):729-36.

  12. Globe DR, Curtis RG, Koerper MA. Utilization of care in haemophilia: a resource-based method for cost analysis from the Haemophilia Utilization Group Study (HUGS). Haemophilia 2004; 10 Suppl 1:63-70.

  13. Globe DR, Cunningham WE, Andersen R, Dietrich SL, Curtis RG, Parish KL, Miller RT, Sanders NL, Kominski G. The Hemophilia Utilization Group Study (HUGS): determinants of costs of care in persons with haemophilia A. Haemophilia 2003; 9(3):325-31.

  14. Globe DR, Cunningham WE, Andersen R, Dietrich SL, Curtis RG, Parish KL, Miller RT, Sanders NL, Kominski G. Haemophilia Utilization Group Study: assessment of functional health status in haemophilia. Haemophilia 2002; 8(2):121-8.

  15. Globe DR, Cunningham WE, Andersen RM, Dietrich SL, Curtis RB, Parish KL, Miller RT, Sanders NL and Kominski GF. The Hemophilia Utilization Group Study (HUGS): cost of out-patient, in-patient and pharmaceutical care. Intern J of Pediatric Hematology/Oncology 2001; 7(2): 87-100.